PRESS RELEASE published on 09/09/2026 at 07:30, 2 months 8 days ago Just – Evotec Biologics Advances U.S. Department of War Antibodies Against Orthopoxvirus into Phase 1 Clinical Studies Just \/ Evotec Biologics advances investigational antibodies against orthopoxviruses into Phase 1 clinical studies under U.S. Department of War Accelerated Antibodies Program, supporting biodefense preparedness Biodefense U.S. Department Of War Orthopoxviruses Just \/ Evotec Biologics Phase 1 Clinical Studies
BRIEF published on 09/02/2026 at 07:35, 2 months 15 days ago Evotec et Plectonic collaborent sur des approches à base de lymphocytes T pour les tumeurs solides Evotec SE Immunothérapie Tumeurs Solides Plectonic Biotech Engagement Des Lymphocytes T
BRIEF published on 09/02/2026 at 07:35, 2 months 15 days ago Evotec and Plectonic Collaborate on T-Cell Approaches for Solid Tumors Evotec SE Solid Tumors Immunotherapy Plectonic Biotech T-cell Engagement
PRESS RELEASE published on 09/02/2026 at 07:30, 2 months 15 days ago Evotec and Plectonic Enter Research Collaboration to Explore New Generation of T-Cell-Engaging Approaches for Solid Tumors Evotec SE and Plectonic Biotech collaborate on a new T-cell-engaging immunotherapy approach for solid tumors, combining BiTco costimulatory platform with LOGIBODY technology Evotec SE Solid Tumors Immunotherapy Plectonic Biotech T-cell-engaging
BRIEF published on 08/06/2026 at 07:35, 3 months 11 days ago Evotec et Odyssey Therapeutics unissent leurs forces dans la découverte de médicaments guidée par l'IA Evotec SE Maladies Inflammatoires Maladies Auto-immunes Odyssey Therapeutics Découverte Pilotée Par L'IA
BRIEF published on 08/06/2026 at 07:35, 3 months 11 days ago Evotec and Odyssey Therapeutics Join Forces in AI-Driven Drug Discovery Evotec SE Inflammatory Diseases Autoimmune Diseases Odyssey Therapeutics AI-driven Discovery
BRIEF published on 08/06/2026 at 07:35, 3 months 11 days ago Evotec and Odyssey Therapeutics Form AI-Driven R&D Partnership Drug Discovery Autoimmune Diseases Milestone Payments Evotec Collaboration AI-driven R&D
BRIEF published on 08/06/2026 at 07:35, 3 months 11 days ago Evotec et Odyssey Therapeutics concluent un partenariat de R&D axé sur l'IA Maladies Auto-immunes Paiements D'étape Découverte De Médicaments Collaboration Evotec Recherche Et Développement Pilotés Par L'IA
PRESS RELEASE published on 08/06/2026 at 07:30, 3 months 11 days ago Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases Evotec SE and Odyssey Therapeutics collaborate on AI-enabled R&D for autoimmune and inflammatory diseases, aiming to discover new treatments. Collaboration combines expertise and technology to accelerate drug discovery Inflammatory Diseases Autoimmune Diseases Evotec R&D Collaboration Odyssey Therapeutics
PRESS RELEASE published on 08/06/2026 at 07:30, 3 months 11 days ago Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases Evotec SE and Odyssey Therapeutics collaborate on AI-enabled R&D for autoimmune and inflammatory diseases, leveraging expertise and advanced technologies Evotec SE Inflammatory Diseases Autoimmune Diseases Odyssey Therapeutics AI-enabled R&D
Published on 11/18/2026 at 00:35, 2 hours 12 minutes ago Route1 Appoints Tom Park to Board of Directors and Announces Board Changes
Published on 11/17/2026 at 23:40, 3 hours 7 minutes ago AI/ML Innovations Inc. Closes First Tranche of Private Placement
Published on 11/17/2026 at 23:00, 3 hours 47 minutes ago Alset AI Ventures Inc. Announces Extension of Annual General Meeting Deadline
Published on 11/17/2026 at 21:30, 5 hours 17 minutes ago Fairplay Ventures INC. Announces Filing of Filing Statement in Connection With Qualifying Transaction
Published on 11/17/2026 at 15:00, 11 hours 47 minutes ago Secure Blockchain's Agentic Solutions Signs Engineering Company, Expanding Enterprise AI Into Heavy Industry
Published on 11/18/2026 at 01:55, 52 minutes ago WIRobotics and Ottobock Join Forces to Expand Access to Wearable Robots Across North America
Published on 11/18/2026 at 01:40, 1 hour 7 minutes ago AMPERA and Berto Announce Proposed Business Combination to Accelerate Advanced Energy Technology Development and Commercialization
Published on 11/18/2026 at 00:59, 1 hour 48 minutes ago Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 11/17/2026 at 23:13, 3 hours 34 minutes ago EQS-Adhoc: M1 Kliniken AG plans move to the Prime Standard in 2027 and raises EBIT margin target for its Beauty segment to at least 25%
Published on 11/17/2026 at 22:00, 4 hours 47 minutes ago Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 11/17/2026 at 18:00, 8 hours 47 minutes ago 20261117 - Accor - Accor to increase its stake in Ennismore
Published on 11/17/2026 at 18:00, 8 hours 47 minutes ago Accor - Accor se renforce au capital de Ennismore
Published on 11/17/2026 at 17:45, 9 hours 2 minutes ago EURAZEO COMPLETES THE SALE OF ITS STAKE IN AROMA-ZONE AND ITS REINVESTMENT ALONGSIDE PARTNERS GROUP
Published on 11/17/2026 at 17:45, 9 hours 2 minutes ago EURAZEO FINALISE LA CESSION DE SA PARTICIPATION DANS AROMA-ZONE ET SON REINVESTISSEMENT AUX COTES DE PARTNERS GROUP
Published on 11/17/2026 at 07:40, 19 hours 6 minutes ago SUEZ INTERNATIONAL SAS COMPLETES THE SALE OF C.10.65 MILLION SHARES OF ACEA S.P.A.